secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2023-10-16T23:59:59+00:00
Accession:  0001013762-23-004127
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.02, 2.03, 3.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx acquires Medicx Health for $95M; preannounces Q3 revenue $15.2-$15.5M
--------------------------------------------------------------------------------

- Acquires Medicx Health for $95M in cash; closing expected Q4 2023; management to reinvest ~$10.5M in OPRX common stock.
- New $40M term loan from Blue Torch Finance at Reference+7.5% or SOFR+8.5%; leverage ratio covenants step down from 4.50:1 to 2.00:1.
- Preliminary Q3 2023 revenue $15.2M-$15.5M; non-GAAP net income $0.6M-$1.0M; ahead of consensus.
- Stephen Silvestro appointed President effective at merger close; steps down as Chief Commercial Officer.
- Combined revenue run rate ~$100M; acquisition expected to be immediately accretive to earnings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000101376223004127/0001013762-23-004127-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000101376223004127/ea186749-8k_optimizerx.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-004127

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer